Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells
Lydie Cassard, … , Wolf H. Fridman, Catherine Sautès-Fridman
Lydie Cassard, … , Wolf H. Fridman, Catherine Sautès-Fridman
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1549-1557. https://doi.org/10.1172/JCI15454.
View: Text | PDF
Article Development

Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells

  • Text
  • PDF
Abstract

Research Article

Authors

Lydie Cassard, Joël F.G. Cohen-Solal, Annie Galinha, Xavier Sastre-Garau, Claire Mathiot, Jérôme Galon, Thierry Dorval, Alain Bernheim, Wolf H. Fridman, Catherine Sautès-Fridman

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
The development of human melanomas is independent of FcγRIIB1 expression...
The development of human melanomas is independent of FcγRIIB1 expression in SCID mice. (a) Tumor uptake, determined by inoculation of 2 × 106 721.1 or 721.2 cells or 1 × 106 A375, A375IIB1, HT144, HT144IIB(Cyto–), or HT144IIB1 cells in SCID mice. Results are expressed as percentage of mice (n = 18) that remained tumor-free after challenge in two experiments. (b) Tumor growth, measured by volume after inoculation of 4 × 106 721.1 or 721.2 cells or 2 × 106 A375, A375IIB1, HT144, HT144IIB(Cyto–), or HT144IIB1 cells. Nine mice were used per experiment in each group, and mean tumor volume values, with SD, of mice bearing tumor are shown. Data are representative of two independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts